Abstract
This research aimed to isolate and identify Staphylococcus aureus and Candida species from throat infections, as well as assess their antibiotic resistance. Samples were collected from both infected patients and healthy individuals, encompassing various ages and genders, in hospitals of Najaf province between December 2022 and March 2023. The findings revealed that S. aureus constituted 36.10% of isolates, followed by S. warneri at 22.81%, and S. lugdunensis at 15.29%. Notably, S. aureus isolates displayed 100% resistance to Penicillin (P), Aztreonam (ATM), and Oxacillin (OX), Amoxicillin (AMC) and Tetracycline (TE) exhibiting resistance rates of 81.95% and 78.19%, respectively. The study concluded that S. aureus was the predominant strain, followed by S. warneri. Antibiotic susceptibility testing on all S. aureus isolates (n=21) was conducted using seven selected antibiotics. Candida species identified included Candida albicans, Candida parapsilosis, and Candida glabrata, with maximum resistance observed against fluconazole (FLU) and polymyxin B (PB), followed by miconazole (MCL).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal Of Health & Medical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
